Bio-Techne India Profile
Key Indicators
- Authorised Capital ₹ 1.98 Cr
as on 24-10-2024
- Paid Up Capital ₹ 1.98 Cr
as on 24-10-2024
- Company Age 7 Year, 13 Days
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 50.00 K
as on 24-10-2024
- Revenue 26.19%
(FY 2023)
- Profit 26.42%
(FY 2023)
- Ebitda 7.26%
(FY 2023)
- Net Worth 18.28%
(FY 2023)
- Total Assets 7.18%
(FY 2023)
About Bio-Techne India
The Company is engaged in the Life Sciences Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.98 Cr and a paid-up capital of Rs 1.98 Cr.
The company currently has active open charges totaling ₹50,000.00.
Anand Khetan, James Hippel, and Shane Bohnen serve as directors at the Company.
- CIN/LLPIN
U51909MH2017FTC302647
- Company No.
302647
- Company Classification
Private Limited Foreign Company Incorporated In India
- Incorporation Date
08 Dec 2017
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Bio-Techne India Private Limited offer?
Bio-Techne India Private Limited offers a wide range of products and services, including Machines & Equipments, SPM Machine.
Who are the key members and board of directors at Bio-Techne India?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Anand Khetan  | Director | 14-Mar-2019 | Current |
James Hippel  | Director | 08-Dec-2017 | Current |
| Shane Bohnen | Director | Current |
Financial Performance and Corporate Structure Insights of Bio-Techne India.
Bio-Techne India Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 26.19% increase. The company also saw a substantial improvement in profitability, with a 26.42% increase in profit. The company's net worth Soared by an impressive increase of 18.28%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Bio-Techne India?
In 2023, Bio-Techne India had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Burkert Fluid Control Systems India Private LimitedActive 1 year 6 monthsAnand Khetan is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 28 Aug 2020 | ₹0.05 M | Open |
How Many Employees Work at Bio-Techne India?
Bio-Techne India has a workforce of 10 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Bio-Techne India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Bio-Techne India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
